These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis. Kullar R; McClellan I; Geriak M; Sakoulas G Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897 [TBL] [Abstract][Full Text] [Related]
5. Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment. Chaves RL; Chakraborty A; Benziger D; Tannenbaum S J Antimicrob Chemother; 2014 Jan; 69(1):200-10. PubMed ID: 24030545 [TBL] [Abstract][Full Text] [Related]
6. Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis. Salama NN; Segal JH; Churchwell MD; Patel JH; Gao L; Heung M; Mueller BA Clin J Am Soc Nephrol; 2009 Jul; 4(7):1190-4. PubMed ID: 19541812 [TBL] [Abstract][Full Text] [Related]
7. Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation. Lewis SJ; Jang SM; Mueller BA BMC Nephrol; 2023 Sep; 24(1):270. PubMed ID: 37710245 [TBL] [Abstract][Full Text] [Related]
8. [Daptomycin in the treatment of Gram-positive infections in patients with chronic renal failure]. Sarriá Cepeda C Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():38-42. PubMed ID: 22541974 [TBL] [Abstract][Full Text] [Related]
9. Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis. Butterfield JM; Mueller BA; Patel N; Cardone KE; Grabe DW; Salama NN; Lodise TP Antimicrob Agents Chemother; 2013 Feb; 57(2):864-72. PubMed ID: 23208714 [TBL] [Abstract][Full Text] [Related]
10. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study. Kielstein JT; Eugbers C; Bode-Boeger SM; Martens-Lobenhoffer J; Haller H; Joukhadar C; Traunmüller F; Knitsch W; Hafer C; Burkhardt O Nephrol Dial Transplant; 2010 May; 25(5):1537-41. PubMed ID: 20031929 [TBL] [Abstract][Full Text] [Related]
11. Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis. Vilay AM; Grio M; Depestel DD; Sowinski KM; Gao L; Heung M; Salama NN; Mueller BA Crit Care Med; 2011 Jan; 39(1):19-25. PubMed ID: 20890189 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry. Martone WJ; Lamp KC Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448 [TBL] [Abstract][Full Text] [Related]
14. Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration. Wenisch JM; Meyer B; Fuhrmann V; Saria K; Zuba C; Dittrich P; Thalhammer F J Antimicrob Chemother; 2012 Apr; 67(4):977-83. PubMed ID: 22210754 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752 [TBL] [Abstract][Full Text] [Related]
16. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria. Katz DE; Lindfield KC; Steenbergen JN; Benziger DP; Blackerby KJ; Knapp AG; Martone WJ Int J Clin Pract; 2008 Sep; 62(9):1455-64. PubMed ID: 18662172 [TBL] [Abstract][Full Text] [Related]
17. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species. DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618 [TBL] [Abstract][Full Text] [Related]
18. Comparing outcomes of meropenem administration strategies based on pharmacokinetic and pharmacodynamic principles: a qualitative systematic review. Perrott J; Mabasa VH; Ensom MH Ann Pharmacother; 2010 Mar; 44(3):557-64. PubMed ID: 20124468 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies. Rose WE; Rybak MJ; Kaatz GW J Antimicrob Chemother; 2007 Aug; 60(2):334-40. PubMed ID: 17540670 [TBL] [Abstract][Full Text] [Related]
20. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques. Lewis SJ; Mueller BA J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]